22 Apr 2026
What Is a Trichome and Why Does It Matter in Medical Cannabis?
The Biology of Trichomes: Cannabis’s Chemical Factories Trichomes are microscopic glandular structures found on the surface of cannabis flower and leaves Three…
Read More →Patient Guides & Clinical Insights
Medical Cannabis UK — Blog & Patient Guides
Expert information on medical cannabis prescriptions, conditions, strains and patient experiences in the United Kingdom. Written by clinicians, reviewed for accuracy.
22 Apr 2026
Returns and Disposal of Cannabis Prescriptions in UK Pharmacies
Why Patient Returns of Cannabis Are Common Patients frequently return unused cannabis when they discontinue treatment, switch products, or experience adverse effects…
Read More →
21 Apr 2026
Cannabis Prescription Labelling Requirements in the UK
Legal Requirements for Controlled Drug Labels All dispensed cannabis products must be labelled in accordance with the Human Medicines Regulations 2012 Labels…
Read More →
21 Apr 2026
Patient Counselling for Cannabis Dispensing: A Pharmacist’s Guide
The Importance of Pharmacist-Led Patient Counselling Pharmacists are the last clinical checkpoint before the patient receives their cannabis medication Effective counselling at…
Read More →
21 Apr 2026
Schedule 2 Controlled Drug Storage Requirements for Cannabis
Legal Framework: The Misuse of Drugs (Safe Custody) Regulations Cannabis stored in pharmacies and clinics must comply with the Misuse of Drugs…
Read More →
20 Apr 2026
How Dispensing Pharmacies Handle Cannabis Prescriptions
The Role of the Dispensing Pharmacy in the Cannabis Pathway Only pharmacies with a Schedule 2 controlled drug licence can legally dispense…
Read More →
20 Apr 2026
Cannabis and Safeguarding: Prescribing Safely for Vulnerable Patients
Safeguarding Obligations in Cannabis Prescribing UK law and GMC guidance require prescribers to consider safeguarding in all clinical interactions Vulnerable adults and…
Read More →
20 Apr 2026
Cannabis and Polypharmacy: Prescribing Safely in Complex Patients
Why Polypharmacy Matters in Cannabis Prescribing The average UK medical cannabis patient takes 3–5 concurrent medications at the time of initiation Cannabis…
Read More →
19 Apr 2026
Adverse Event Reporting for Cannabis Prescribers in the UK
The UK Yellow Card Scheme and Cannabis The MHRA Yellow Card Scheme is the UK’s national pharmacovigilance system for reporting adverse drug…
Read More →
19 Apr 2026
Patient Monitoring and Follow-Up Protocol for Cannabis Prescribers
Why Structured Follow-Up Is Non-Negotiable in Cannabis Prescribing Cannabis is a Schedule 2 controlled drug — prescribers carry enhanced duty of care…
Read More →